» Authors » Xue-Chun Lu

Xue-Chun Lu

Explore the profile of Xue-Chun Lu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 347
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Song Y, Zhang H, Song X, Geng J, Li H, Zhang L, et al.
World J Clin Oncol . 2024 Jan; 15(1):115-129. PMID: 38292661
Background: Multiple myeloma (MM) is a terminal differentiated B-cell tumor disease characterized by clonal proliferation of malignant plasma cells and excessive levels of monoclonal immunoglobulins in the bone marrow. The...
2.
Li H, Zhang J, Lu X
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2023 Apr; 31(2):581-584. PMID: 37096537
Duodenal-type follicular lymphoma (DFL) is a unique subtype of follicular lymphoma (FL), which often involves the second portion of duodenum (descending part of duodenum). Due to its specific pathological features,...
3.
Wang Z, Chen H, Zhang J, Lu X
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2023 Apr; 31(2):411-419. PMID: 37096513
Objective: To explore the role of ferroptosis-related genes in multiple myeloma(MM) through TCGA database and FerrDb, and build a prognostic model of ferroptosis-related genes for MM patients. Methods: Using the...
4.
Liu G, Chen X, Zhang J, Chen H, Wang Z, Zhi P, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2023 Feb; 31(1):162-169. PMID: 36765494
Objective: To screen the prognostic biomarkers of metabolic genes in patients with multiple myeloma (MM), and construct a prognostic model of metabolic genes. Methods: The histological database related to MM...
5.
Zhang J, Zhang H, Lu D, Wang Z, Chen H, Lu X
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2022 Aug; 30(4):1101-1108. PMID: 35981368
Objective: To screen the differential expression of diffuse large B-cell lymphoma (DLBCL) autophagy-related gene (ARG), explore the mechanism of differential expression of autophagy gene (DEARG) in the occurrence and development...
6.
Xu X, Wang J, Jiang J, Zhang T, Lv X, Wang S, et al.
Adv Parasitol . 2022 Jun; 116:115-152. PMID: 35752446
This article summarizes the background, specific conditions, main measures, steps and effects of the implementation of Mass Drug Administration (MDA) to control the local P. vivax malaria epidemic in Anhui...
7.
Ge F, Si L, Yang Y, Li Y, Lv Z, Liu W, et al.
Front Pharmacol . 2021 Nov; 12:756975. PMID: 34776974
Liuweiwuling Tablet (LWWL) is a licensed Chinese patent medicine (approval number: Z20060238) included in the national health insurance for anti-inflammation of chronic HBV infection, whereas its anti-HBV effect remains clarification....
8.
Wang X, Guo B, Zhai B, Yang B, Fan H, Lu X, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2021 Aug; 29(4):1136-1140. PMID: 34362493
Objective: To evaluate the efficacy and safety of CHOP regimen based on doxorubicin hydrochloride liposome in the initial treatment of elderly patients with diffuse large B-cell lymphoma (DLBCL). Methods: Thirty-one...
9.
Zhang J, Yang B, Chen H, Chi X, Chen X, Zhi P, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2021 Jun; 29(3):975-982. PMID: 34105503
Objective: To analyze and predict the effect of coronavirus infection on hematopoietic system and potential intervention drugs, and explore their significance for coronavirus disease 2019 (COVID-19). Methods: The gene expression...
10.
Su Q, Li T, He P, Lu X, Yu Q, Gao Q, et al.
Alzheimers Res Ther . 2021 Jan; 13(1):7. PMID: 33397436
Background: Alzheimer's disease (AD) is an intractable neurodegenerative disorder in the elderly population, currently lacking a cure. Trichostatin A (TSA), a histone deacetylase inhibitor, showed some neuroprotective roles, but its...